节点文献

高通量筛选JAK-STAT6信号传导通路抑制剂方法的初步建立

Identification of inhibitors that target JAK-STAT6 signal pathway via high-throughput screening

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 笪宇蓉姚智李静雅邵洁沈强东莉洁李佳杨洁

【Author】 DA Yu-rong1,YAO Zhi1,LI Jing-ya2, SHAO Jie1,SHEN Qiang2 ,DONG Li-jie1 ,LI Jia2 ,YANG Jie1 (1.Dept of Immunology, Tianjin Medical University, Tianjin 300070,China; 2.National Center for Drug Screening, Shanghai 201203,China)

【机构】 天津医科大学免疫教研室中科院上海药物所国家新药筛选中心天津医科大学免疫教研室 天津300070天津300070上海201203

【摘要】 目的构建可用于高通量筛选JAK/STAT6信号传导通路抑制剂的工程细胞株,建立稳定可靠的筛选方法。方法利用基因重组和转染技术,将STAT6特异性识别启动子IgE基因序列和虫荧光素酶报告基因联合插入pCMV质粒,脂质体法转染至HeLa细胞,经潮红霉素B抗性筛选及报告基因检测,得到稳定表达虫荧光素酶的工程细胞株。通过优化溶剂DMSO浓度,IL4作用浓度及孵育时间等筛选条件,建立了可靠的筛选方法,并在此基础上对1600种化合物进行了筛选。结果建立的筛选方法稳定可靠,系统Z′因子达到0.64。通过对1600种化合物的筛选,得到3个抑制效果较理想的化合物并测得其IC50值。结论所建立的高通量筛选方法可用于JAK/STAT6信号传导通路抑制剂的筛选。

【Abstract】 Aim To establish the stable cell line which expresses luciferase depending on STAT6-mediated gene transcriptional activation. The cell line is used as a model to screen compounds that inhibit JAK- STAT6 signal transduction pathway. Methods The sequence of IgE promoter and luciferase reporter gene were subcloned into the vector to generate recombinant plasmid, which can express luciferase after IL-4 stimulation. The recombinant plasmid was cotransfected into HeLa cells together with hygromycin B DNA. The positive cell clones were selected in the culture media which contains hygromycin B. Some factors such as final concentration of DMSO and working concentration of IL-4 were measured to optimize the assay condition. 1600 compounds were screened by the method. Results A JAK-STAT6 activation depended cell model was setupand a reliable method was established to perform high throughput screening. Z′-factor value of the system was near 0.64. Three compounds were screened to have suppressive effect on JAK-STAT6 pathway. Conclusion This assay can be applied to identify inhibitors targeting JAK-STAT6 signal transduction pathway.

【基金】 国家自然科学基金资助项目(No30300070);国家教育部新世纪人才支持计划(NCET-04-0245);高等学校博士学科点专项科研基金资助项目(No20040062003);天津市应用基础研究重点资助项目(No043802811);天津医科大学自然科学基金资助项目(No2005KY01)
  • 【文献出处】 中国药理学通报 ,Chinese Pharmacological Bulletin , 编辑部邮箱 ,2006年08期
  • 【分类号】Q789
  • 【被引频次】7
  • 【下载频次】480
节点文献中: